IgGenix logo

IgGenix jobs and careers

South San Francisco, CA, United States

About IgGenix

IgGenix is an early-stage, venture backed biotechnology company founded on breakthrough advances in Steve Quake’s laboratory at Stanford in collaboration with allergy clinician and researcher Kari Nadeau. They work on translating research discoveries into transformative therapies for individuals suffering from allergies.

Founded in 2019 by Bruce Hironaka, Derek Croote, Jessica Grossman, Kari Nadeau, Richard Boismenu and Stephen Quake.

Founded
2019
Employees
11 to 50
Total funding
$75M
Headquarters
South San Francisco

Leadership

The top of IgGenix's org chart, with how many people report into each leader.

JGPhoto of Jessica Grossman

Jessica Grossman

CEO

5 reports

HL

Henry Lowman

Interim Chief Scientific Officer

2 reports

DCPhoto of Derek Croote

Derek Croote

Co-founder & Chief Technical Officer

LNPhoto of Laurence Nore

Laurence Nore

EVP, Business Development & Operations; Director of IgGenix Australia Pty Ltd

Board

SK

Samir Kaul

Director

KN

Kari Nadeau

Scientific Advisor

HO

Hans Oettgen

Scientific Advisor

JW

Jim Wells

Scientific Advisor

SQ

Stephen Quake

Director

SS

Scott Smith

Scientific Advisor